Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
出版年份 2018 全文链接
标题
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma
作者
关键词
Lipid metabolism, Melanoma cancer stem cells, BRAF, MEK inhibitors
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-12-17
DOI
10.1186/s13046-018-0989-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Recent developments and obstacles in the treatment of melanoma with BRAF and MEK inhibitors
- (2018) Mohd Wahid et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The viable circulating tumor cells with cancer stem cells feature, where is the way out?
- (2018) Y. T. Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN
- (2018) Hui Ran et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Correction to: Emerging role of lipid metabolism alterations in Cancer stem cells
- (2018) Mei Yi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- Metabolic features of cancer stem cells: the emerging role of lipid metabolism
- (2018) Rita Mancini et al. ONCOGENE
- Notch Signaling Enhances Stemness by Regulating Metabolic Pathways Through Modifying p53, NF-κB, and HIF-1α
- (2018) Hiroyuki Moriyama et al. STEM CELLS AND DEVELOPMENT
- Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells
- (2018) Norashikin Zakaria et al. Frontiers in Oncology
- Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials
- (2017) Dirk Schadendorf et al. EUROPEAN JOURNAL OF CANCER
- Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4
- (2017) Jihua Nie et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features
- (2017) Ayele Argaw-Denboba et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
- (2017) A Noto et al. ONCOGENE
- miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
- (2017) Rita El Helou et al. Cell Reports
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- miR-579-3p controls melanoma progression and resistance to target therapy
- (2016) Luigi Fattore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines
- (2016) Daniela Kovacs et al. Oncotarget
- Ferritin heavy chain is a negative regulator of ovarian cancer stem cell expansion and epithelial to mesenchymal transition
- (2016) Nadia Lobello et al. Oncotarget
- NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer
- (2016) Karla Vazquez-Santillan et al. Scientific Reports
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target
- (2015) Christina A. von Roemeling et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
- (2015) Luigi Fattore et al. Oncotarget
- Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas
- (2015) Devin G. Roller et al. Oncotarget
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Mitogen-activated Protein Kinase (MAPK) Hyperactivation and Enhanced NRAS Expression Drive Acquired Vemurafenib Resistance in V600E BRAF Melanoma Cells
- (2014) Michael Lidsky et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Lung Cancer Stem Cell Lose Their Stemness Default State after Exposure to Microgravity
- (2014) Maria Elena Pisanu et al. Biomed Research International
- Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
- (2013) Luigi Fattore et al. Journal of Translational Medicine
- The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis
- (2013) Jasper Wouters et al. PLoS One
- Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells
- (2013) A Noto et al. Cell Death & Disease
- DNA Damage Repair Pathways in Cancer Stem Cells
- (2012) M. Maugeri-Sacca et al. MOLECULAR CANCER THERAPEUTICS
- Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
- (2012) Hubing Shi et al. Nature Communications
- Preexisting MEK1 Exon 3 Mutations in V600E/K BRAF Melanomas Do Not Confer Resistance to BRAF Inhibitors
- (2012) Hubing Shi et al. Cancer Discovery
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Cancer Stem Cells and Chemosensitivity
- (2011) M. Maugeri-Sacca et al. CLINICAL CANCER RESEARCH
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
- (2011) Rita Mancini et al. PLoS One
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Acidic stress promotes a glioma stem cell phenotype
- (2010) A B Hjelmeland et al. CELL DEATH AND DIFFERENTIATION
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
- (2009) Zhizhong Li et al. CANCER CELL
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now